Patrick Hwu/X
Aug 27, 2025, 14:51
Patrick Hwu: Promising New 3-Drug Combo for Melanoma Immunotherapy
Patrick Hwu, President and CEO at Moffitt Cancer Center, shared a post on LinkedIn:
“Congrats to Keiran Smalley and team on their new Journal for ImmunoTherapy of Cancer paper!
A 3-drug immunotherapy combo may overcome resistance in melanoma, restoring immune response and shrinking tumors in preclinical models without added side effects.
Title: Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma models
Authors: Manali S Phadke, Jiannong Li, Sathya Sriramareddy, Paulo C Rodriguez, Brian Ruffell, Vincent C Luca, Thuy T T Tran, Yian Ann Chen, Keiran S M Smalley
More posts featuring Patrick Hwu on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 27, 2025, 14:51
Aug 27, 2025, 14:28
Aug 27, 2025, 13:56
Aug 27, 2025, 13:19